Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Zerumbone** is a natural monocyclic sesquiterpene (phytochemical cyclic ketone) primarily isolated from the rhizomes of *Zingiber zerumbet* (a ginger of the Zingiberaceae family)[2][7]. It displays a broad spectrum of biological activities: antitumor (via selective apoptosis of various cancer cell lines by upregulating TRAIL death receptors DR4/DR5 and downregulating cFLIP), antioxidant, anti-inflammatory (inhibiting lipocalin-2, production of reactive oxygen species, cytokines such as IL-6, IL-1β, TNF-α), antimicrobial, anti-nociceptive, immunomodulatory, anti-diabetic, anti-hyperlipidemic, hepatoprotective, gastroprotective, and anti-proliferative effects[1][2][3][4][7][8]. Zerumbone acts on multiple molecular pathways including NF-κB inhibition, reactive oxygen species mediation, modulation of p53, Bax, and p21, with some efficacy in preclinical models of learning/memory impairment and neuroinflammation[1][2][3]. It is highly lipophilic, with poor aqueous solubility and limited oral bioavailability, and is mostly researched for its potential as a dietary supplement and investigational drug for chronic inflammatory, neoplastic, and neurodegenerative diseases[2][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zerumbone.